GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Stock Information for Integrity Applications

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Integrity Applications

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights
Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt
Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering
GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE
GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING
JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS
GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.